BI Asset Management Fondsmaeglerselskab’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $229M | Buy |
191,037
+52,724
| +38% | +$53.9M | 1.82% | 10 |
|
|
2026
Q1 | $127M | Sell |
138,313
-34,210
| -20% | -$34.7M | 1.33% | 14 |
|
|
2025
Q4 | $184M | Buy |
172,523
+46,908
| +37% | +$44.9M | 1.63% | 9 |
|
|
2025
Q3 | $95M | Sell |
125,615
-23,522
| -16% | -$17.5M | 0.86% | 22 |
|
|
2025
Q2 | $115M | Buy |
149,137
+38,960
| +35% | +$30.3M | 1.14% | 12 |
|
|
2025
Q1 | $91M | Sell |
110,177
-16,891
| -13% | -$14.1M | 1.02% | 16 |
|
|
2024
Q4 | $98.1M | Buy |
127,068
+27,412
| +28% | +$22.7M | 1.03% | 14 |
|
|
2024
Q3 | $88.3M | Buy |
99,656
+43,015
| +76% | +$38.7M | 1.53% | 8 |
|
|
2024
Q2 | $51.3M | Buy |
56,641
+3,431
| +6% | +$2.74M | 0.84% | 24 |
|
|
2024
Q1 | $41.4M | Buy |
53,210
+15,018
| +39% | +$10.7M | 0.78% | 28 |
|
|
2023
Q4 | $22.3M | Sell |
38,192
-68,131
| -64% | -$39.8M | 0.47% | 59 |
|
|
2023
Q3 | $57.1M | Buy |
106,323
+9,052
| +9% | +$4.66M | 1.33% | 11 |
|
|
2023
Q2 | $45.6M | Buy |
97,271
+8,212
| +9% | +$3.44M | 1.08% | 17 |
|
|
2023
Q1 | $30.6M | Sell |
89,059
-45,377
| -34% | -$15.3M | 0.81% | 22 |
|
|
2022
Q4 | $49.2M | Buy |
134,436
+19,504
| +17% | +$6.92M | 1.31% | 14 |
|
|
2022
Q3 | $37.2M | Buy |
114,932
+2,977
| +3% | +$943K | 1.89% | 10 |
|
|
2022
Q2 | $36.3M | Sell |
111,955
-33,551
| -23% | -$10.1M | 1.55% | 10 |
|
|
2022
Q1 | $41.7M | Buy |
145,506
+8,727
| +6% | +$2.25M | 1.6% | 8 |
|
|
2021
Q4 | $37.8M | Sell |
136,779
-10,366
| -7% | -$2.63M | 1.39% | 12 |
|
|
2021
Q3 | $34M | Sell |
147,145
-22,169
| -13% | -$5.47M | 1.29% | 15 |
|
|
2021
Q2 | $38.9M | Sell |
169,314
-33,912
| -17% | -$6.81M | 1.49% | 10 |
|
|
2021
Q1 | $38M | Buy |
203,226
+4,437
| +2% | +$868K | 1.54% | 9 |
|
|
2020
Q4 | $33.6M | Sell |
198,789
-23,603
| -11% | -$3.52M | 1.46% | 16 |
|
|
2020
Q3 | $32.9M | Buy |
222,392
+49,990
| +29% | +$7.74M | 1.5% | 12 |
|
|
2020
Q2 | $28.3M | Sell |
172,402
-16,040
| -9% | -$2.46M | 1.45% | 18 |
|
|
2020
Q1 | $26.1M | Sell |
188,442
-57,626
| -23% | -$7.92M | 1.55% | 19 |
|
|
2019
Q4 | $32.3M | Sell |
246,068
-21,088
| -8% | -$2.44M | 1.53% | 20 |
|
|
2019
Q3 | $29.9M | Buy |
267,156
+39,827
| +18% | +$4.43M | 1.47% | 23 |
|
|
2019
Q2 | $25.2M | Buy |
227,329
+39,579
| +21% | +$4.66M | 1.2% | 41 |
|
|
2019
Q1 | $24.4M | Buy |
187,750
+39,850
| +27% | +$4.85M | 1.23% | 41 |
|
|
2018
Q4 | $17.1M | Sell |
147,900
-29,600
| -17% | -$3.31M | 1.09% | 39 |
|
|
2018
Q3 | $19M | Buy |
177,500
+16,500
| +10% | +$1.65M | 1.19% | 34 |
|
|
2018
Q2 | $13.7M | Buy |
+161,000
| New | +$13.2M | 0.98% | 43 |
|
Other funds holding LLY
N
BI Asset Management Fondsmaeglerselskab's LLY Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $53.9M and bringing the position to 191,037 shares worth $229M. The position accounts for 1.82% of the portfolio, ranked #10.
BI Asset Management Fondsmaeglerselskab first reported a position in LLY in Q2 2018 and has held it in 33 quarters since. 3,332 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 191,037 shares of Eli Lilly worth $229M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab bought 52,724 Eli Lilly shares in Q2 2026, an estimated $53.9M.
- Eli Lilly made up 1.82% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #10 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Eli Lilly in Q2 2018 and has held it in 33 quarters since.
- 3,332 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.